Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.
The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.
The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.
Publications found:
866
Sort by:
Measles, Mumps and Rubella (MMR) Vaccines Market 2026
US$ 2,999.00
The Measles, Mumps and Rubella (MMR) Vaccines Market was valued at in and is anticipated to reach by , at a CAGR of 0.1 from 2026 to 2032. The report delivers in-depth insights into key market dynamic...
October 2025
220 pages
Adult Vaccines Market Outlook 2025-2034: Market Share, and Growth Analysis By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Viral or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines), By Application, By End Users
US$ 3,950.00
The Adult Vaccines Market is valued at USD 20.6 billion in 2025 and is projected to grow at a CAGR of 8.6% to reach USD 43.1 billion by 2034.The Adult Vaccines Market is a specialized sector focused o...
October 2025
160 pages
Travel Vaccines Market Outlook 2025-2034: Market Share, and Growth Analysis By Disease (Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,), By Composition (Mono Vaccines, Combination Vaccines), By Booking Channel, By Application
US$ 3,950.00
The Travel Vaccines Market is valued at USD 6.5 billion in 2025 and is projected to grow at a CAGR of 9.7% to reach USD 14.9 billion by 2034.The Travel Vaccines Market is a critical component of globa...
October 2025
160 pages
Chickenpox Vaccine Market Outlook 2025-2034: Market Share, and Growth Analysis By Vaccine (Monovalent varicella vaccine, Combination varicella vaccine), By Application (Mumps, Measles, Rubella, And Varicella Immunization, Herpes Zoster Immunization, Chickenpox Vaccination), By End-Users
US$ 3,950.00
The Chickenpox Vaccine Market is valued at USD 4.5 billion in 2025 and is projected to grow at a CAGR of 7.4% to reach USD 8.6 billion by 2034.The chickenpox vaccine market plays a vital role in globa...
October 2025
160 pages
Human Papillomavirus (Hpv) Vaccine Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Tetravalent, Nonavalent, Bivalent), By Disease Indication (Cervical Cancer, Anal Cancer, Vulvar And Vaginal Cancer, Penile Cancer, Oropharyngeal Cancer, Other Indications), By Distribution Channel, By Industry Vertical
US$ 3,950.00
The Human Papillomavirus (Hpv) Vaccine Market is valued at USD 8.2 billion in 2025 and is projected to grow at a CAGR of 14.1% to reach USD 26.8 billion by 2034.The Human Papillomavirus (HPV) Vaccine...
October 2025
160 pages
Plant-Based Vaccines Market Outlook 2025-2034: Market Share, and Growth Analysis By Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types), By Source (Tobacco Plant, Maize, Potato, Other Sources), By Application
US$ 3,950.00
The Plant-Based Vaccines Market is valued at USD 2.1 billion in 2025 and is projected to grow at a CAGR of 10.7% to reach USD 5.2 billion by 2034. Plant-Based Vaccines Market Overview The plant-based...
October 2025
160 pages
Quadrivalent Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Intradermal Shot, Intramuscular Injection, Nasal Spray), By Technology (Conjugated, Live, Inactivated, Recombinant, Toxoid, Other Technologies), By Disease, By Age Group, By Distribution Channel
US$ 3,950.00
The Quadrivalent Market is valued at USD 11.4 billion in 2025 and is projected to grow at a CAGR of 8.4% to reach USD 23.6 billion by 2034. Market Overview The global quadrivalent vaccine market has e...
October 2025
160 pages
Respiratory Disease Vaccine Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine), By Infection (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other Infections), By Age, By End-User
US$ 3,950.00
The Respiratory Disease Vaccine Market is valued at USD 57.3 billion in 2025 and is projected to grow at a CAGR of 2.5% to reach USD 71.3 billion by 2034.The Respiratory Disease Vaccine Market has bec...
October 2025
160 pages
Global Therapeutic Vaccines Market Growth 2025-2031
US$ 3,660.00
The global Therapeutic Vaccines market size is predicted to grow from US$ 52540 million in 2025 to US$ 167680 million in 2031; it is expected to grow at a CAGR of 21.3% from 2025 to 2031. The impact o...
October 2025
94 pages
Global Human Combination Vaccines Market Growth 2025-2031
US$ 3,660.00
The global Human Combination Vaccines market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest...
October 2025
105 pages
Global H1N1 Vaccines Market Growth 2025-2031
US$ 3,660.00
The global H1N1 Vaccines market size is predicted to grow from US$ 4903 million in 2025 to US$ 5946 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031. The impact of the lates...
October 2025
104 pages
Global HPV Vaccines Market Growth 2025-2031
US$ 3,660.00
The global HPV Vaccines market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff m...
October 2025
86 pages
Global MMR Vaccines Market Growth 2025-2031
US$ 3,660.00
The global MMR Vaccines market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff m...
October 2025
84 pages
Global Rotavirus Infections Drug Market Growth 2025-2031
US$ 3,660.00
The global Rotavirus Infections Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest...
October 2025
91 pages
Global Tick-borne Encephalitis Vaccine Market Growth 2025-2031
US$ 3,660.00
... forecast to 2023. To understand the structure of Tick-borne Encephalitis Vaccine market by identifying its various subsegments. Focuses on the key global Tick-borne Encephalitis Vaccine manufacturers, to define, describe and analyze the ...
October 2025
82 pages
Global DT-Based Combined Vaccines Market Growth 2025-2031
US$ 3,660.00
The global DT-Based Combined Vaccines market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest...
October 2025
106 pages
Global Human Tetanus Immunoglobulin Market Growth 2025-2031
US$ 3,660.00
The global Human Tetanus Immunoglobulin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the late...
October 2025
101 pages
Global Human Rotavirus Vaccine Market Growth 2025-2031
US$ 3,660.00
The global Human Rotavirus Vaccine market size is predicted to grow from US$ 202 million in 2025 to US$ 248 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031. The impact of t...
October 2025
78 pages
Global Virus Like Particles Market Growth 2025-2031
US$ 3,660.00
The global Virus Like Particles market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S....
October 2025
116 pages
Global Measles Vaccine Market Growth 2025-2031
US$ 3,660.00
The global Measles Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tarif...
October 2025
119 pages
Global H7N9 Vaccines Market Growth 2025-2031
US$ 3,660.00
The global H7N9 Vaccines market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff...
October 2025
79 pages
Global Vaccine Isothermal Transport Box Market Growth 2025-2031
US$ 3,660.00
... Research objectives To study and analyze the global Vaccine Isothermal Transport Box consumption (value & volume) by key ... the structure of Vaccine Isothermal Transport Box market by identifying its various subsegments. Focuses on the key global Vaccine Isothermal Transport Box manufacturers, to define ...
October 2025
124 pages
Global Cancer Vaccines Market - 2025 -2033
US$ 4,350.00
Global Cancer Vaccines Market: Industry Outlook The global cancer vaccines market reached US$ 8.82 Billion in 2023, with a rise of US$ 9.27 Billion in 2024 and is expected to reach US$ 14.96 Billion b...
October 2025
180 pages
Global Pediatric Vaccine Market - 2025 -2033
US$ 4,350.00
Pediatric Vaccine Market Size The global pediatric vaccine market size reached US$ 23.25 Billion in 2024 and is expected to reach US$ 38.53 Billion by 2033, growing at a CAGR of 5.8% during the foreca...
October 2025
180 pages
Global Vaccine Adjuvants Market - 2025 -2033
US$ 4,350.00
Vaccine Adjuvants Market Size & Industry Outlook The global vaccine adjuvants market size reached US$ 703.15 Million in 2024 from US$ 661.09 Million in 2023 and is expected to reach US$ 1,280.35 Milli...
October 2025
180 pages
Asia Pacific Cervical Cancer Vaccines Market Size, Share, Trends & Analysis by Vaccine Type (Preventive Vaccine, Therapeutic Vaccine), by Technology (Molecular-based, Vector-based, Others), by Distribution Channel (Hospitals, Clinics, Government Entities) and Region, with Forecasts from 2025 to 2034.
US$ 3,670.00
The Asia Pacific Cervical Cancer Vaccines Market is expected to witness robust growth between 2025 and 2034, fueled by government-led immunization initiatives, rising awareness of human papillomavirus...
September 2025
198 pages
Europe Cervical Cancer Vaccines Market Size, Share, Trends & Analysis by Vaccine Type (Preventive Vaccine, Therapeutic Vaccine), by Technology (Molecular-based, Vector-based, Others), by Distribution Channel (Hospitals, Clinics, Government Entities) and Region, with Forecasts from 2025 to 2034.
US$ 3,670.00
The Europe Cervical Cancer Vaccines Market is projected to experience strong growth from 2025 to 2034, supported by rising awareness of HPV-related diseases, government-led vaccination programs, and c...
September 2025
200 pages
Global Cervical Cancer Vaccines Market Size, Share, Trends & Analysis by Vaccine Type (Preventive Vaccine, Therapeutic Vaccine), by Technology (Molecular-based, Vector-based, Others), by Distribution Channel (Hospitals, Clinics, Government Entities) and Region, with Forecasts from 2025 to 2034.
US$ 3,970.00
The Global Cervical Cancer Vaccines Market is projected to witness robust growth from 2025 to 2034, driven by increasing awareness about cervical cancer prevention, rising government immunization init...
September 2025
216 pages
North America Cervical Cancer Vaccines Market Size, Share, Trends & Analysis by Vaccine Type (Preventive Vaccine, Therapeutic Vaccine), by Technology (Molecular-based, Vector-based, Others), by Distribution Channel (Hospitals, Clinics, Government Entities) and Region, with Forecasts from 2025 to 2034.
US$ 3,670.00
The North America Cervical Cancer Vaccines Market is expected to witness steady growth between 2025 and 2034, driven by strong government vaccination programs, rising public awareness about HPV-relate...
September 2025
205 pages
Global Aluminum Adjuvanted Vaccines Market Growth 2025-2031
US$ 3,660.00
The global Aluminum Adjuvanted Vaccines market size is predicted to grow from US$ 816 million in 2025 to US$ 1417 million in 2031; it is expected to grow at a CAGR of 9.6% from 2025 to 2031. The mecha...
September 2025
99 pages
